Approved in India as Oxemia for anemia, desidustat stimulates erythropoietin, a signaling molecule secreted in response to ...
Women with SCD experience significant healthcare challenges, a study found, with researchers calling for training on ...
Women with sickle cell disease (SCD) experience significant challenges with healthcare while struggling with both the ...
Pfizer’s recent decision to withdraw Oxbryta (voxelotor) from global markets feels like a devastating blow for many people with sickle cell disease. Oxbryta’s conditional approval in 2019 by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback